News – Page 596 – Endpoints News

Allogene wins a major reprieve for its leading off-the-shelf cell therapy pipeline

4 years ago

Maze Therapeutics refuels with another $190M to prove its genetic modifiers approach holds up in the clinic

4 years ago

FDA approves potential blockbuster insomnia drug, a first for Swiss biotech Idorsia

4 years ago

How durable is durable? BioMarin gears up to bring hemophilia A gene therapy to FDA again with 2-year data

4 years ago

In $900M+ deal, rare disease biotechs team up on RNA therapies for CNS developmental disorders

4 years ago

Pfizer, the new master of mRNA delivery, teams up with Beam to ship base editors straight to target tissues

4 years ago

Bayer jumps on board Mammoth's ultra-small CRISPR tech with sights set first on the liver

4 years ago

Three AI deals kick off #JPM22 weekend; Can Silicon Valley change how science gets funded?; Special report: 2021 new ...

4 years ago

Digital doctors’ message to pharma marketers: Lay off email deluge and ramp up custom content

4 years ago

A new startup thinks it's found a key to drugging 'disordered' proteins — and it has plenty of cash to get started

4 years ago

Anacor veterans raise $80M in bid to tackle rare lung disease with boron-based inhibitors

4 years ago

Cytokinetics gets the Royalty treatment, snagging up to $450M to support closely watched heart programs

4 years ago

Merck revs up dealmaking engine ahead of #JPM22, inking collaborations with AI protein design player Absci

4 years ago

ALS player Amylyx bags $190M as it sets sail on Nasdaq amid choppy waters

4 years ago

Regeneron hands off ex-US rights for cholesterol disorder drug to rare disease specialist Ultragenyx

4 years ago

Fujifilm Diosynth adds on at its NC hub, bolstering lab space with plans to bring on 145 new jobs

4 years ago

How family and science moved Exelixis' new CMO to work on oncology blockbusters; While John Maraganore racks up the ...

4 years ago

Aligos crumbles after axing lead asset, as analysts rue another flop in 'beaten-down' sector

4 years ago

Covid-19 roundup: FDA shortens interval for Moderna booster dose to 5 months; Moderna CEO says another booster could ...

4 years ago

Planting another flag on Pfizer and Alnylam's turf, AstraZeneca grabs amyloidosis drug from the biotech that invented ...

4 years ago

FDA loses FOIA suit over Pfizer vaccine documents, must release 55,000 pages per month

4 years ago

Sanofi, Exscientia ink the next AI megadeal, signing terms on a $100M upfront pact with up to 15 drugs on the line

4 years ago

Covid-19 manufacturing roundup: Ritonavir production to reach 100M doses annually; Schumer calls for a boost to ...

4 years ago

Novo Holdings picks up injectables CDMO in push for single-use manufacturing tech

4 years ago

First page Previous page 593 594 595596597 598 599 Next page Last page